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ORIGINAL ARTICLE
Results of Polysomnographies and Treatment Strategies 
in Elderly Patients with Symptoms of Obstructive Sleep 
Apnea Syndrome
OBJECTIVES: In this study, we evaluated data regarding the management of geriatric patients with symptoms of obstructive sleep apnea 
syndrome (age, >65 years) who were admitted to our sleep clinic. 
MATERIAL AND METHODS: Symptoms and sleep data of the patients were retrospectively evaluated, and the patients were reevaluated 
after treatment.
RESULTS: A total of 85 patients with a median age of 69 years were included. Snoring and fatigue were the most common symptoms. 
Cardiovascular diseases were the most frequently listed comorbidity. The median Epworth sleepiness scale was 10, and based on Berlin 
sleep questionnaire findings, 63.5% of the participants were in the high-risk group. Eighty-seven percent were diagnosed with obstruc-
tive sleep apnea (2/3 of them were positional), and moderate-to-severe obstructive sleep apnea was observed more in women than in 
men. Only one patient was diagnosed with central sleep apnea. There were positive and linear correlations between increased age and 
the apnea-hypopnea index, arousal index, Epworth sleepiness scale, and being in a high-risk group according to the Berlin sleep scale; 
however, there was no correlation between increased age and the number of hypopnea and apnea events. There were also positive and 
linear correlations between the apnea-hypopnea index and the Epworth sleepiness scale, being in a high-risk group according to the 
Berlin sleep questionnaire, an increased number of known medical conditions, and increased body mass index. We were able to contact 
72 of the 85 patients via phone calls. Patients who adjusted to treatment had positive feedbacks.
CONCLUSION: Sleep disorders are observed more in the elderly, and an increasing age is an independent factor for sleep disorders. Be-
sides the usual signs and symptoms of sleep disorders, it should be considered in elderly who have cognitive dysfunction and dementia.
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INTRODUCTION
The proportion of elderly people (age, >65 years) has been increasing, particularly in developing countries. The World 
Health Organization has estimated that the population of people aged >65 years will be 1.5 billion by 2050 [1]. Although 
some people age without having any serious illnesses, some elderly might have “pathological aging” with significant 
comorbidities that lead to functional impairment [2]. One way or another, the elderly may complain of changes in sleep 
habits such as difficulty falling asleep and maintaining sleep, with frequent nocturnal awakenings and early morning 
awakening; thus, sleep gets more fragmented and consequently lighter [3]. Because of the changes in sleep architecture 
or physiological and/or pathological changes owing to aging, elderly people may report increased daytime sleepiness and 
fatigue as well as concentration and memory problems [4]. These symptoms can also occur because of obstructive sleep 
apnea syndrome (OSAS), which is characterized by nocturnal episodes of upper airway obstruction, sleep fragmentations, 
and hypoxemia [5]. These symptoms might be under-recognized in elderly patients because the presence of the symp-
toms might be accepted by patients, caregivers, or even by doctors as a “natural” occurrence of aging.
Obstructive sleep apnea defined as anapnea-hypopnea index (AHI) of >5/h is commonly observed in elderly (age >65 years), 
with a large range of incidence (5%-75%). Prevalence of OSAS ncreases with age, with a conservative estimation of double the 
prevalence in younger age groups [6]. There are several mechanisms associated with this age-related increase, including reduc-
tion in pharyngeal muscle function, age-related differences in pharyngeal morphology (including a decrease in the size of the 
upper airway lumen), increase in arousal frequency that leads to periodic breathing, and increase in the prevalence of obesity 
andcomorbidities [including congestive heart failure and neurocognitive impairment (such as dementia and stroke)] [7].
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Symptoms of sleep disorders are similarly observed in both 
younger and older populations [5]. However, there might 
be a great variability in the level of sleepiness with the same 
degree of OSAS. Obesity is main risk factor of OSAS and is 
reported to be less important in the elderly who usually 
have a lower body mass index (BMI) and neck circumfer-
ence than in younger OSAS patients [3]. Polysomnography 
(PSG) is the gold standard diagnostic tool for evaluating 
OSAS, but only a small percentage of people at risk for 
OSAS have access to PSG, and using PSG in elderly popula-
tions with multiple comorbidities may be difficult [8]. 
Treatment options are similar for younger and older 
patients, as recommended by the American Academy of 
Sleep Medicine (AASM) [9]. 
In this study, we evaluated data regarding the management of 
geriatric patients with OSAS symptoms (age,>65 years) who 
were admitted to our sleep clinic. We assessed the correla-
tion between age and sleep parameters, including the sever-
ity of the sleep disorder, and attempted to clarify the charac-
teristics of sleep problems among elderly people. Moreover, 
the patients were re-evaluated and adherencerates to sug-
gested treatment options were also assessed.
MATERIAL AND METHODS
Subjects
Eighty-five patients with a suspected diagnosis of OSAS and 
who were aged >65 years and were admitted to the sleep 
clinic at Baskent University Istanbul Hospital between 
January 2013 and December 2015 were enrolled in the 
study. After 6 months, these patients were contacted by tele-
phone, and informed consent was obtained from the patients. 
Of 85 patients, 72 could be contacted, and their symptoms 
of OSAS and their adherence to treatment were assessed. 
The study was conducted according to the guidelines of the 
Declaration of Helsinki and was approved by the ethics com-
mittee of Baskent University.
Demographic Data and Clinical Conditions
Baseline demographic characteristics, symptoms, and comor-
bidities were recorded on the basis of the responses given in 
the questionnaires filled at the outpatient clinic. The Epworth 
sleepiness scale (ESS) and Berlin sleep questionnaire (BSQ) 
scores, which predict the level of daytime somnolence and 
likelihood of OSAS, were recorded.
Sleep Study
All subjects underwent nocturnal PSG testing with the same 
polygraphic device (Grass Comet) at our sleep laboratory 
following the protocol of AASM [9]. Sleep studies were 
scored and analyzed according to the AASM recommenda-
tions by a medical doctor certified in sleep medicine. Other 
sleep disturbances such as central sleep apnea were exclud-
ed according to the PSG results. AHI, computed as the ratio 
of apneas and hypopneas per hour, was used to define the 
presence (i.e., AHİ of ≥5/h) and severity of OSAS (5-15 as 
mild, 15-30 as moderate, and >30 as severe) [9]. Titration 
studies with noninvasive ventilation (Resmed, S9, autocpap), 
as described by AASM, were performed in selected OSAS 
patients.
Statistical Analysis
IBM Statistical Package for the Social Sciences 21.0 (IBM Corp.; 
Armonk, NY, USA) and MedCalc statistical software were used 
in the statistical analysis. Descriptive statistics (frequency, per-
centage, mean (±), median [min-max]) were used to evaluate 
the numerical data in the study. The independent-sample t-test 
was used to compare parameters between the evaluated groups. 
For the analysis of difference between groups, non-parametric 
Mann-Whitney U tests and Kruskal-Wallis tests were used. 
Spearmen’s correlation analysis was used to evaluate the rela-
tionship between age and AHI, arousal index, and number of 
apneas and hypopneas. Moreover, the relation between AHI 
and BMI, ESS, and BSQ scores was evaluated. Results were 
determined with 95% confidence intervals, and a p value <0.05 
was considered statistically significant.
RESULTS
A total of 85 patients with a median age of 69 years (range, 
65-88 years) were enrolled. Demographic data, symptoms, 
and comorbidities are summarized in Table 1. Snoring and 
fatigue were the most common symptoms. Cardiovascular 
disease (including hypertension and other heart diseases) 
was the most frequently listed comorbidity. As expected with 
aging, comorbidities were quite common. Comorbidities, 
such as chronic obstructive pulmonary disease (COPD) and 
cardiovascular diseases, or symptoms, such as memory prob-
lems, were assessed using standard procedures by specialists. 
Our patients were sleepy during the daytime, with a median 
ESS score of 10 (range, 1-24). On the basis of BSQ findings, 
63.5% of patients were in the high-risk group.
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Table 1. Demographic data, symptoms, and comorbidities 
of patients
Variables n
Age (IQR), years 69.0 (67-74)
Sex (male/female)  52/33
BMI (IQR) 29.1 (25.7-36.9)
Symptoms (n, %) 
 Snoring 81 (95.3)
 Fatigue 75 (88.2)
 Apnea 55 (64.7)
 Daytime sleepiness 51 (60.0)
 Waking up with a feeling of being drowned 41 (48.2)
 Memory problems 37 (43.5)
 Headache 21 (24.7)
Comorbidities (n, %) 
 Hypertension  65 (76.4)
 Heart disease* 37 (43.5)
 Diabetes 36 (42.3)
 COPD, asthma, and other lung diseases  14 (16.4)
 Others  29 (34.1)
 Number of comorbidities (IQR) 2.52 (1.25-3.0)
IQR: interquartile range; COPD: chronic obstructive pulmonary 
disease 
*Coronary arterial disease, congestive heart failure, arrhythmias 
Seven patients were administered alprozalam because of dif-
ficulty in falling asleep. Sleep efficiency and other PSG data 
are shown in Table 2. Twelve percent of patients (n=10) were 
diagnosed with simple snoring. Eighty-seven percent of the 
enrolled patients (n=74) were diagnosed with OSAS, with 
16.4% (n=14) being mild, 30.5% (n=26) being moderate, 
and 40% (n=34) being severe OSAS. Nearly two-thirds of 
them were positional(in supine position AHI> 5, and in non-
supine AHI <5) (n=46). Moderate-to-severe OSAS was 
observed more in women than in men [39 women vs. 21 
men (p<0.05)]. Only one patient was diagnosed with central 
sleep apnea.
Rhinolaryngeal examination, positional therapy, and PAP 
treatment were the treatment options planned for the 
patients. Positional therapy and rhinolaryngeal examination 
were planned for 17 mild OSAS patients, and based on the 
rhinolaryngological examination findings, the severity of 
OSAS, and patients’ preferences, two patients underwent a 
nasalseptum operation and one was treated with an oral 
appliance. For 61 patients, PAP treatment was planned; one 
of them had central sleep apnea and 60 patients had moder-
ate-to-severe OSAS. Nine of the 60patients with moderate-to-
severe OSAS refused to undergo titration. Finally, PAP treat-
ment wasinitiated for the one central apnea patient and other 
51 moderate-to-severe OSAS patients. Treatment options are 
summarized in Table 3. After 6 months wereevaluated the 
patients via phone calls, and their adherence to treatment, 
outcomes, and symptoms were assessed. We were able to 
contact 72 of 85 patients via phone calls. We couldnot reach 
three of nine patients who refused to undergo titration, and 
among the remaining six patients, only one got better with 
lifestyle modifications (BMI decreased from 33 to 24), 
whereasthe other five patients continued to have sleep distur-
bances. Forty-five patients who regularly used their devices 
(6.2±1.8 h/day for 6.3±0.7 days/week) had positive feed-
backs, and most of their symptoms got better and their sleep 
disturbances reduced. We recommended all patients to 
change the mask each year, but only 37.8% of them renewed 
their mask yearly. Besides PAP treatment, 30 patients were 
recommended for other treatment options. We were able to 
contact 90% of the patients in this group, and 81% of them 
had positive feedbacks. People whose symptoms did not 
improve were the ones who did not comply with our sugges-
tions.
We also performed a correlation analysis and evaluated if 
there was an association between age and the number of 
apnea-hypopnea events, AHI, arousal index, BSQ score, ESS 
score, and periodic limb movement index (PLMI). We 
observed a positive and linear correlation between increased 
age and AHI, arousal index, being in a high-risk group 
according to BSQ scores, and ESS scores; however, there was 
no correlation between increased age and the number of 
apnea-hypopnea events or PLMI (Figure 1, Table 4). We also 
performed a correlation analysis between AHI and ESS 
scores, being in a high-risk group according to BSQ scores, 
increased number of known medical condition, and 
increased BMI value, and there was a positive and linear cor-
relation between AHI and all these parameters (Table 4).
DISCUSSION
This study was a summary of the data of an elderly popula-
tion who were admitted to our sleep clinic. Snoring was the 
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Table 2. Polysomnography results
Variables (IQR) 
Sleep efficiency, % of TRT 77.9 (68.8-88.6)
Arousal index, /h 31.8 (18.5-49.4)
Total number of hypopnea events 63.0 (26.0-123.0)
Total number of apnea events 35.0 (8.5-79.5)
AHI, /h 24.2 (11.7-43.1)
Minimum oxygen saturation, %  82.0 (76.0-86.75)
Duration of oxygen desaturation  2.7 (0.15-19.5) 
(<88%), % of TST 
PLMI 2.45 (0-14.1)
IQR: interquartile range; AHI: apnea-hypopnea index; NREM: non-
rapid eye movement; TST: total sleep time; TRT: total recording time; 
PLMI: periodic limb movement index
Table 4. Results of correlation analyses between 
evaluated parameters
  Correlation  
	 Variables	 coefficient	 p
 AHI 0.223 0.038
AGE ESS score 0.253 0.022
 Arousal index 0.246 0.038
 High risk in BSQ score 0.329 0.016
 ESS score 0.457 0.001
AHI High risk in BSQ score 0.620 0.001
 Number of medical conditions 0.215 0.031
 BMI 0.351 0.019
AHI: apnea-hypopnea index; ESS: Epworth sleepiness scale; BSQ: 
Berlin sleep quality; BMI: body mass index
Table 3. Treatment choices planned for the sleep apnea 
patients
Treatment option  n/%
PAP treatment 52 (69.3)
 CPAP 35 (46.6)
 BIPAP 10 (13.3)
 BIPAP-ST 4 (5.0)
 AUTO-CPAP 2 (2.6)
 ASV 1 (1.3)
Nasal septum operation   2 (2.6)
Oral appliance  1 (1.4)
Positional therapy  14 (16.4)
PAP: positive airway pressure; CPAP: continuous positive airway 
pressure; BIPAP-ST: bilevel positive airway pressure; ASV: adaptive 
servoventilation
most observed symptom, and the patients mostly complained 
of fatigue. Most patients (60%) had moderate-to-severe 
OSAS, and we preferred PAP (mostly CPAP) treatment for 
such patients. No treatment was offered to people with AHI 
of <5. We first planned rhinolaryngological examination for 
people with AHI of 5-15, and if necessary, surgery was 
offered. The main aim of the study was to determine the risk 
of increasing age on sleep parameters, and we observed that 
increased age was a risk factor for increased AHI, arousal 
index, ESS score, and being in a high-risk group according to 111
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Figure 1. a-f. Correlation between age and sleep parameters. (a) Correlation between age and AHI. (b) Correlation between age and arousal 
index. (c) Correlation between age and ESS scores. (d) Correlation between age and being high risk in BSQ scores. (e) Correlation between 
age and the number of hypopnea events. (f) Correlation between age and the number of apnea events.
AHI: Apnea-hypopnea index; BSQ: Berlin sleep questionnaire; ESS: Epworth sleep scale
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BSQ scores. There was a positive and linear association 
between AHI and BMI, increased ESS scores, being in a high-
risk group according to BSQ scores, and an increased num-
ber of known medical conditions. Most patients who adjust-
ed to the PAP treatment and tried other treatment options had 
positive feedbacks.
Increased age, polypharmacy, and obesity are known risk fac-
tors for sleep disturbances [10]. In our study, the probability of 
observing OSAS was more in elderly people with more medi-
cal conditions and whose BMI was high. There was no differ-
ence in OSAS between men and women in our population 
(87% of men and 86% of women had AHI of >5); however, 
moderate-to-severe OSAS was observed more in women. 
Duran et al. [11] suggested similar results (80% of women and 
81% of men had AHI of >5). The prevalence of OSAS is 2-3-
fold lower in pre-menopausal women than in males, and with 
respect to post-menopausal women, the prevalence is equal 
[12]. Protective function of estrogen is lost in elderly in 
women because of menopause. At younger ages the preva-
lence of OSAS is more in men, however in elderly the preva-
lence of OSAS is more in women, and it may be related to loss 
of protective function of estrogen at that age group. Therefore 
hormone replacement therapy has been suggested as a thera-
peutic intervention for elderly women with OSAS [13]. In our 
study group, the most important risk factor for OSAS was obe-
sity, andthe probability of having OSAS was 35.5% greater 
among obese patients than among those with normal BMI. In 
the current literature, it is estimated that overall, 50%-60% of 
obese people have OSAS [14], and obesity is a major risk fac-
tor for OSAS. Obesity promotes the enlargement of soft tissue 
structures within and surrounding the airway, contributing to 
pharyngeal airway narrowing. In contrast, impaired glucose 
metabolism in OSAS might be the reason for metabolic syn-
drome and obesity [15].
Snoring, fatigue, daytime sleepiness, and cessation of breath 
during sleep were the most common signs and symptoms we 
observed, and these symptoms can be observed in both 
young and elderly people with sleep disorders [5]. We also 
observed dementia and headache in our population. 
Dementia observed more in elderly people, and it may be 
directly related to OSAS. Day-time somnolence and sleep 
fragmentations may be the reason of cognitive dysfunction 
and also dementia. Therefore all the symptoms of dementia 
should not be associated with natural mechanism of getting 
older, moreover OSAS should also be considered in patients 
with symptoms of dementia. [16]. Such findings could sim-
ply occur because of the comorbidities in elderly people, but 
chronic hypoxia during sleep can cause neural injury, and 
this may be another reason for cognitive dysfunction and 
headache [17]. The overexpression of the apolipoprotein E 
(APOE) gene is observed in both Alzheimer disease and 
OSAS, and this may be another reason for the observed 
dementia in people with sleep disorders [18]. 
In elderly populations, age-related differences in pharyngeal 
morphology and reduction in pharyngeal muscle function 
are observed [19], and these are the basic mechanisms of 
OSAS in elderly people. In our study group, there was a 
positive and a linear association between age and AHI. As 
the age of our patients increased, the probability of a high 
arousal index increased, and it was previously shown that 
arousal frequency increases with age [20]. Our clinic is a 
sleep center in an university hospital, and most of our 
patients were referred from other clinics such as cardiology, 
endocrine and metabolism, and nephrology; therefore, these 
patients tended to have multiple comorbidities. We observed 
that the diagnosis of OSAS was more probable as the number 
of medical conditions increased. An increased number of 
comorbidities or polypharmacy can be the reason for sleep 
disturbances in elderly populations [21]. Diuretic therapy or 
diseases such as benign prostate hyperplasia might cause 
nocturia, or people with chronic renal or heart failure may 
have ortopnea or PND; and all of these may affect the sleep 
quality [22]. Being high risk in BSQ and having high ESS 
scores are positively and linearly correlated with both 
increased age and high AHI score, similar to that reported in 
previous studies [5,7,23]. In contrast, there have been studies 
in which ESS and BSQ scores had low accuracies for dis-
criminating subjects with or without OSAS. Sforza et al. [8] 
showed that the third item of BSQ hypertension is not appro-
priate for discriminating OSAS because many people in this 
age group have hypertension; therefore, this item should only 
comprise obesity. Because of the decrease in symptom 
awareness in elderly people, ESS and BSQ scores might have 
limited use as indicators of sleep disorders [8,24]. Higher 
values of PLMI have been observed in elderly populations 
[25,26]; however, the median value of PLMI in our study 
group was 2.45, and there was no association between PLMI 
values and increased age. 
Treatment options depend on the severity of sleep disease 
and the patient’s symptoms. All patients were encouraged to 
pursue lifestyle modifications, including weight loss, cessa-
tion of smoking, increased exercise, and reduced consump-
tion of alcohol and caffeine. Oral appliances and positional 
measures were preferred for people with symptomatic mild 
and moderate sleep disorders. PAP treatment is the mainstay 
therapy choice for moderate-to-severe sleep disorders [27]. 
Nearly 70% of our patients who followed our suggested 
treatment option got better, and 80% of them had positive 
feedbacks about symptom-related outcomes and quality of 
life. There have been a few prospective cohort studies in 
which outcomes of symptoms of sleep apnea patients were 
observed after CPAP treatment. Similar to our results, in these 
studies, improvement in sleep quality, cognitive functions, 
and quality of life were observed [28,29]. It was observed 
both in our study and previous studies that people who use 
PAP treatment regularly have perfect outcomes [30,31].
This study has some limitations. We could have had more 
exact results if the study was prospectively designed, and the 
measurements of the records of sleep data in the PAP devices 
would have been better than phone calls. 
In conclusion, sleep disorders are observed more in the 
elderly, and increasing age is an independent risk factor for 
sleep disorders. Besides the usual signs and symptoms of 
SDB such as snoring, daytime somnolence, and fatigue, 
OSAS should be considered in the elderly who have cogni-
tive dysfunction or dementia. 
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